Nudging Patients to Increase Shingles Vaccination

Description

The purpose of this study is to test whether messages encouraging patients to ask about a Shingrix vaccine at an upcoming appointment will increase Shingrix vaccination rates. The study will also test which of several message versions is most effective.

Conditions

Shingles, Vaccination Behavior, Behavior, Health

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to test whether messages encouraging patients to ask about a Shingrix vaccine at an upcoming appointment will increase Shingrix vaccination rates. The study will also test which of several message versions is most effective.

Nudging Patients to Increase Shingles Vaccination

Nudging Patients to Increase Shingles Vaccination

Condition
Shingles
Intervention / Treatment

-

Contacts and Locations

Danville

Geisinger Clinic, Danville, Pennsylvania, United States, 17822

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 50+
  • * Has not received any doses of the Shingrix vaccine according to the Geisinger EHR
  • * Has a non-acute in-person Geisinger primary care appointment in a department that stocks Shingrix scheduled with enough time to be randomized
  • * Cannot be contacted via the communication modality being used in the study (e.g., patient portal, SMS), e.g., due to insufficient/missing contact information in the EHR or because they opted out
  • * Patient does not have an approved insurance on file for Shingrix outreach for their appointment type or department
  • * Appointment type or department not approved for outreach by Geisinger leadership at the time of outreach
  • * While a separate flu vaccination nudge campaign is running (approximately from September through December, 2024), patients will be excluded if they have not received a flu shot in the 2024-25 flu season according to the EHR. Such patients will be eligible for inclusion again as soon as the flu vaccination campaign ends.

Ages Eligible for Study

50 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Geisinger Clinic,

Christopher F Chabris, PhD, PRINCIPAL_INVESTIGATOR, Geisinger Clinic

Study Record Dates

2025-05-13